Skip to content
Medical Health Aged Care

Penta Unveils Brighter Future Award 2023: Recognising Innovators and Visionaries Driving Positive Change

Fondazione Penta ETS 3 mins read

Penta announces the inaugural Brighter Future Award to honour maternal and child health champions

PADOVA, ITALY / ACCESSWIRE / June 15, 2023 / Penta, an international independent scientific network dedicated to maternal and child health research, is proud to unveil the Brighter Future Award (BFA), an annual global event designed to celebrate the remarkable efforts of individuals and organisations working tirelessly to improve health outcomes for children and pregnant individuals living with infectious diseases worldwide.

Penta Brighter Future Award
Penta Brighter Future Award
An illustration diverse group of children holding hands with the Fondazione Penta ETS logo

As we acknowledge the vital role of local champions in driving positive change, the BFA aims to recognise these outstanding change-makers and provide opportunities for scientists to connect with and learn from local communities at the forefront of maternal and child health.

"Our children are our future, and their well-being should be a shared responsibility that transcends scientific boundaries. Only by fostering collaboration, advocacy, and policy changes can we ensure that the scientific advancements translate into tangible improvements for every child, paving the way for a healthier, brighter tomorrow," said Carlo Giaquinto, President of Fondazione Penta ETS and Professor of Paediatrics at the University of Padua, Italy.

Seven winners will be selected by an international jury of experts in their fields. The winners will each receive a €5,000 prize to support their ongoing work. Additionally, the BFA will provide all-expenses-paid trips for the winners to attend the 2024 Penta ID Network meeting in Italy. This prestigious event offers a platform for the winners to share their work with Penta researchers and join a network of like-minded professionals dedicated to child health.

The BFA comprises two categories:

  • Penta's Brighter Future Award: Six awards, one for each of the six global regions
  • Penta's Brighter Future Young Researcher Award: One award to a young researcher in the maternal and child health fields.

Nominations for the Penta BFA are open from June 15 to September 15, 2023. A distinguished panel of experts, including scientists, child health specialists and experts in youth participation in medical research from across the globe, will evaluate the nominations based on criteria such as innovation, sustainability, community engagement and social justice. Winners will be announced on December 1, 2023.

More about the BFA nomination process in this video: https://youtu.be/6bCvobzbExc

By recognising the outstanding efforts of those working to make a real difference in maternal and child health worldwide, we hope to inspire others to follow in their footsteps and work towards creating positive change in their own communities.

For more information about the Brighter Future Award and Penta, please visit https://penta-id.org/bfa.

Contact Information

Francesca Mazzetto
Penta Senior Communications Manager
[email protected]
+393486151202

SOURCE: Fondazione Penta ETS

.


View source version on accesswire.com:
https://www.accesswire.com/761467/Penta-Unveils-Brighter-Future-Award-2023-Recognising-Innovators-and-Visionaries-Driving-Positive-Change

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.